Literature DB >> 14639604

nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation.

Eiji Suzuki1, Tetsuya Ota, Kazunori Tsukuda, Atsushi Okita, Kinya Matsuoka, Masakazu Murakami, Hiroyoshi Doihara, Nobuyoshi Shimizu.   

Abstract

The nm23-H1 gene is known as a potential metastasis suppressor gene in various types of carcinomas. However, the role of nm23-H1 in colorectal carcinoma still remains controversial and the cellular mechanisms by which its protein may modulate the metastatic phenotype are not yet known. We transfected nm23-H1 cDNA into the human colon cancer cell line, HT-29, to test the effects and cellular biological mechanism of nm23 protein in colon cancer. We found that nm23-H1 strongly inhibited the liver metastasis of HT-29 cells in nude mice and inhibited the epidermal growth factor (EGF)-induced cell migration in vitro. Furthermore, we clarified the regulation of the myosin light chain (MLC) phosphorylation by nm23-H1, which has been demonstrated as having potential role in cell migration. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14639604     DOI: 10.1002/ijc.11546

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

Review 1.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

Review 2.  Understanding h-prune biology in the fight against cancer.

Authors:  Natascia Marino; Massimo Zollo
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

3.  Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

Authors:  Maria I Almeida; Milena S Nicoloso; Lizhi Zeng; Cristina Ivan; Riccardo Spizzo; Roberta Gafà; Lianchun Xiao; Xinna Zhang; Ivan Vannini; Francesca Fanini; Muller Fabbri; Giovanni Lanza; Rui M Reis; Patrick A Zweidler-McKay; George A Calin
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

4.  Mass spectrometry detection of histidine phosphorylation on NM23-H1.

Authors:  John D Lapek; Gregory Tombline; Alan E Friedman
Journal:  J Proteome Res       Date:  2010-12-28       Impact factor: 4.466

Review 5.  Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Authors:  Natascia Marino; Joji Nakayama; Joshua W Collins; Patricia S Steeg
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

7.  PRUNE and NM23-M1 expression in embryonic and adult mouse brain.

Authors:  Pietro Carotenuto; Natascia Marino; Anna Maria Bello; Anna D'Angelo; Umberto Di Porzio; Daniela Lombardi; Massimo Zollo
Journal:  J Bioenerg Biomembr       Date:  2006-10-11       Impact factor: 2.945

Review 8.  Metastasis suppressors and the tumor microenvironment.

Authors:  Leah M Cook; Douglas R Hurst; Danny R Welch
Journal:  Semin Cancer Biol       Date:  2010-12-17       Impact factor: 15.707

9.  A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.

Authors:  Dong-Joo You; Cho Rong Park; Hyun Bok Lee; Mi Jin Moon; Ju-Hee Kang; Cheolju Lee; Seong-Hyun Oh; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

10.  Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Authors:  Jean-Claude A Marshall; Joshua W Collins; Joji Nakayama; Christine E Horak; David J Liewehr; Seth M Steinberg; Mary Albaugh; Fernando Vidal-Vanaclocha; Diane Palmieri; Maryse Barbier; Maximilien Murone; Patricia S Steeg
Journal:  J Natl Cancer Inst       Date:  2012-08-21       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.